Brief: Pharmasgp Holding FY Adjusted EBITDA EUR 19.4 Mln

PharmaSGP Holding SE

15/03/2022 06:34

March 15 (Reuters) - PHARMASGP HOLDING SE  PSGG.DE :
    * PHARMASGP ACHIEVES RECORD RESULTS IN 2021 - ADJUSTED
EBITDA IN
Q4 UP FIVEFOLD YEAR-ON-YEAR
    * FY REVENUES EUR 65.3 MILLION
    * IN Q4 ALONE, ADJUSTED EBITDA AMOUNTED TO EUR 6.2 MILLION,
REPRESENTING A FIVEFOLD INCREASE COMPARED TO SAME QUARTER OF
PREVIOUS YEAR (Q4 2021 COMPARED WITH Q4 2020)
    * FY ADJUSTED EBITDA EUR 19.4 MILLION
    * IN 2021, PHARMASGP GENERATED FY REVENUES OF EUR 65.3
MILLION AT
AN ADJUSTED EBITDA MARGIN OF 29.7%
    * FY ADJUSTED EBITDA MARGIN 29.7%

Source text for Eikon:  ID:nEQ583jCTa 
Further company coverage:  PSGG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))